Marilyn Glassberg, M.D.
Scientific Advisory Committee
Division Chief, Pulmonary Medicine, Critical Care and Sleep Medicine, University of Arizona College of Medicine.
Marilyn Glassberg, M.D., is Chair of Pulmonary Medicine, Critical Care and Sleep Medicine, and Vice-Chair for Diversity and Inclusion, as well as senior director of Clinical Research for Strategy and Growth for the Department of Internal Medicine at the University of Arizona College of Medicine. Dr. Glassberg is a leading expert in rare lung diseases. After completing her undergraduate studies at Wellesley College and initial research training with Drs. Judah Folkman and Bruce Zetter at Harvard Medical School, she completed her medical degree and postgraduate training at the University of Miami Miller School of Medicine and University of Miami Affiliated Hospitals.
Dr. Glassberg runs a basic science research lab in collaboration with Dr. Sharon Elliot, professor of surgery, where they have completed and published seminal studies on the mechanisms of cell-based therapy in fibrotic lung diseases. Dr. Glassberg recently completed the first study of intravenously delivered bone marrow-derived mesenchymal stem cells in patients with idiopathic pulmonary fibrosis (IPF). She has recently received approval from the FDA to conduct ReCell, the first multi-dose randomized, double-blind trial of intravenously delivered mesenchymal stem cells in patients with IPF.
In addition to being a physician-scientist, Dr. Glassberg is the mother of four, a Crossfitter, an avid musician and enthusiast and collector of oriental (Chinese, Burmese, Thai) sculpture and art.
Sign up for the latest lung health news sent right to your inbox.
Join more than 500,000 people who receive research updates, inspiring stories, health information and more.